US FDA Approves Moderna’s mRNA RSV Shot Without Consulting Independent Advisers
The US Food and Drug Administration (US FDA) has approved Moderna’s mRNA respiratory syncytial virus (RSV) vaccine for adults 60...
Day: June 7, 2024
The US Food and Drug Administration (US FDA) has approved Moderna’s mRNA respiratory syncytial virus (RSV) vaccine for adults 60...